The global increase in diabetes mellitus is leading to a parallel increase in the incidence of cardiovascular complications, which remain the leading cause of death in this patient group. In recent years, the discovery of ferroptosis, an iron-dependent and non-apoptotic form of programmed cell death, has provided new insights into the pathophysiology of diabetes-associated heart disease. This review article deepens the understanding of the molecular mechanisms underlying ferroptosis in the cardiovascular system in diabetes and highlights innovative pharmacological and experimental therapeutic approaches that target ferroptosis pathways.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- "Patients W.A.I.T. Indicator"
Access to new drugs is becoming increasingly difficult
- Cardiometabolic research
The liver-heart axis in the pathogenesis of cardiometabolic diseases
- ASCO 2025
Supportive therapies for greater adherence and compliance
- Heart rhythm
From harmonious symphony to age-related dissonance
- Precision therapy
Targeted MET inhibition after progression with osimertinib
- Chronic cough
Differential diagnostic detective work and trial therapies
- Cancer in Europe: facts and analysis
New Health Policy Report published
- Glomerulonephritis: IgA nephropathy